(Q53143666)

11 May 2018

title

Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription. (English)

1 reference

11 May 2018

author name string

I Brana

series ordinal

1

1 reference

11 May 2018

L L Siu

series ordinal

2

1 reference

11 May 2018

publication date

1 September 2012

1 reference

11 May 2018

published in

Annals of Oncology

1 reference

11 May 2018

volume

23 Suppl 10

1 reference

11 May 2018

page(s)

x178-85

1 reference

11 May 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Knowledge and utilization of palliative radiotherapy by pediatric oncologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Human papillomavirus and survival of patients with oropharyngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Human papillomavirus in HNSCC: a European epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) -- recent trends and regional variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

Molecular and Cytogenetic Subgroups of Oropharyngeal Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS322

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS322

1 reference

11 May 2018

1 reference

11 May 2018